GT Biopharma Announces Enrollment Of Patient 10 in GTB-3550 TriKE™ Phase I/II Clinical Trial

BEVERLY HILLS, Calif., April 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

GT Biopharma’s TriKE™ Interim Clinical Trial Results Presented At Innate Killer Summit 2021

Outlines the Clinical Power of Immune Engagement with IL-15 Containing TriKEs BEVERLY…

Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM…

GT Biopharma Announces Updated Interim GTB-3550 Trike™ Clinical Trial Results

Up to 63.7% Reduction in Bone Marrow Blast Levels Restores Patient’s Endogenous…

GT Biopharma to Present at The Virtual 33rd Annual Roth Conference

BEVERLY HILLS, Calif., March 10, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

New Wave: Annouces that Bloom Botanics Ltd. will Launch a New Line of CBD Products in Europe under the brand name ‘Newtriment’

TORONTO, Feb. 1, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company”…

New Wave Holdings subsidiary, Way of Will Inc. is pleased to announce its launch of high-quality mushroom products for Q1 2021

TORONTO, Jan. 14, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New…